Memorial Sloan Kettering Cancer – Healthcare Data News

ConcertAI Announces Agreement with Leading Cancer Center to Accelerate and Transform Precision Oncology Through AI-Enabled Imaging Solutions

CAMBRIDGE, Mass., Nov. 14, 2023 /PRNewswire/ — Today, ConcertAI, the leader in oncology Real-World Data (RWD), Digital Accelerated Clinical Trial solutions, and Clinical Artificial Intelligence imaging interpretation, announced a multi-year strategic agreement...

October 26, 2022October 31, 2022 AI Partner and Collaborator News

UPMC spinoff collaborates with MSK to mine unstructured data for oncology

Realyze Intelligence, which launched in 2021, is working with Memorial Sloan Kettering Cancer Center to apply natural language understanding to real-world patient data. By Mike Miliard October 26, 2022 Photo: Geber86/Getty...

November 18, 2021January 5, 2022 Collaborations Competitor News Data Partnership Oncology

Tempus Incorporates OncoKB Data and NCCN Guidelines Into Its Clinical Reports

Tempus is integrating information from the Memorial Sloan Kettering Cancer Center’s OncoKB database and NCCN Guidelines into its clinical reports, providing physicians robust, well-vetted guidelines at their fingertips Tempus, a...